ArticleJournal of the American Academy of Dermatology2023

Spironolactone use for acne is not associated with an increased risk of venous thromboembolism: A matched, retrospective cohort study.

Ali Shields et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.